Target intelligence / Profile preview

RNA, U2 small nuclear 29, pseudogene (RNU2-29P)

Target
RNU2-29P
Molecular classification
Other
01

Overview

RNU2-29P is annotated as a pseudogene for the U2 small nuclear RNA family and is not known to produce a functional product involved in cellular processes. It does not encode a protein or a functional noncoding RNA, nor is it implicated as a therapeutic target or disease gene. There is no evidence linking RNU2-29P to a specific biological role, disease mechanism, drug interaction, or biomarker utility. The functional U2 small nuclear RNAs are encoded by genes such as RNU2-1 and RNU2-2, with substantial research showing their roles in splicing and neurodevelopmental disorders, but RNU2-29P is not among these functional genes and remains classified as a nonfunctional pseudogene[1][5].\n\nNotes on accuracy:\n- The functional U2 small nuclear RNA-related disease roles and biology as currently described in the literature refer to RNU2-1, RNU2-2, and related functional loci—not to RNU2-29P.\n- RNU2-29P is correctly annotated as a pseudogene with no known therapeutic or biological function[1][5].\n- If you were seeking information on functional U2 small nuclear RNA genes (such as RNU2-2 or RNU2-1), those have significant disease relevance and biological function, but this does not apply to RNU2-29P[2][6].

Other names
RNU2-29PRNA, U2 small nuclear 29, pseudogene

Beyond the preview

Go deeper on RNA, U2 small nuclear 29, pseudogene (RNU2-29P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U2 small nuclear 29, pseudogene (RNU2-29P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call